Exact Mass: 379.0394

Exact Mass Matches: 379.0394

Found 35 metabolites which its exact mass value is equals to given mass value 379.0394, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-Bromo-5-hydroxy-N-(4-hydroxyphenethyl)-4-methoxy-N-methylbenzamide

2-Bromo-5-hydroxy-N-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-N-methylbenzamide

C17H18BrNO4 (379.0419)


   

6-Thioguanosine monophosphate

{[(2R,3S,4R,5R)-5-(2-amino-6-sulfanylidene-6,9-dihydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O7PS (379.0352)


6-Thioguanosine monophosphate is a metabolite of tioguanine. Tioguanine, formerly thioguanine, is a drug that is used in the treatment of cancer. It belongs to the family of drugs called antimetabolites. It is a guanine analog. (Wikipedia) Norcodeine

   

[2,3-e]-1,2-Thiazine-6-sulfonamide 1,1-Dioxide 1

2-methyl-3-[(morpholin-4-yl)methyl]-1,1-dioxo-2H-1lambda6-thieno[2,3-e][1,2]thiazine-6-sulfonamide

C12H17N3O5S3 (379.033)


   

Cyclopenthiazide

6-chloro-3-(cyclopentylmethyl)-1,1-dioxo-3,4-dihydro-2H-1λ⁶,2,4-benzothiadiazine-7-sulfonamide

C13H18ClN3O4S2 (379.0427)


C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

   

[(2R,5R)-5-(2-Amino-6-sulfanylidene-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(2R,5R)-5-(2-Amino-6-sulphanylidene-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphoric acid

C10H14N5O7PS (379.0352)


   
   

Pyridinium-3,5-biscarboxylic acid mononucleotide; P2CMN; Pyridin-1-ium-3,5-dicarboxylate mononucleotide; Pyridinium-3,5-biscarboxylate mononucleotide

Pyridinium-3,5-biscarboxylic acid mononucleotide; P2CMN; Pyridin-1-ium-3,5-dicarboxylate mononucleotide; Pyridinium-3,5-biscarboxylate mononucleotide

C12H14NO11P (379.0304)


   
   

cyclopenthiazide

cyclopenthiazide

C13H18ClN3O4S2 (379.0427)


C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

   

N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide

N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide

C17H18BrNO4 (379.0419)


   

2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl [R-(R*,R*)]-aminoacetate

2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl [R-(R*,R*)]-aminoacetate

C13H15Cl2N3O6 (379.0338)


   

ETHYL 4-(3,5-DICHLOROPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE

ETHYL 4-(3,5-DICHLOROPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE

C17H15Cl2N3O3 (379.049)


   

2-(3-BROMO-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

2-(3-BROMO-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

C19H14BrN3O (379.032)


   

2-[4-(2-phenyl-1,3-thiazol-4-yl)anilino]-1,3-thiazole-4-carboxylic acid

2-[4-(2-phenyl-1,3-thiazol-4-yl)anilino]-1,3-thiazole-4-carboxylic acid

C19H13N3O2S2 (379.0449)


   

L-689,560

(2R,4S)-4-[[anilino(oxo)methyl]amino]-5,7-dichloro-1,2,3,4-tetrahydroquinoline-2-carboxylic acid

C17H15Cl2N3O3 (379.049)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists

   

2-chloro-N-(7-methyl-9-oxo-2-thioxanthenyl)benzamide

2-chloro-N-(7-methyl-9-oxo-2-thioxanthenyl)benzamide

C21H14ClNO2S (379.0434)


   

3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C18H14BrN5 (379.0433)


   

3-Bromo-6-Phenyl-N-(Pyrimidin-5-Ylmethyl)imidazo[1,2-A]pyridin-8-Amine

3-Bromo-6-Phenyl-N-(Pyrimidin-5-Ylmethyl)imidazo[1,2-A]pyridin-8-Amine

C18H14BrN5 (379.0433)


   

3-Bromo-5-Phenyl-N-(Pyrimidin-5-Ylmethyl)pyrazolo[1,5-A]pyridin-7-Amine

3-Bromo-5-Phenyl-N-(Pyrimidin-5-Ylmethyl)pyrazolo[1,5-A]pyridin-7-Amine

C18H14BrN5 (379.0433)


   

3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C18H14BrN5 (379.0433)


   

p-Nitrophenyl-beta-glucoside 6-phosphate

p-Nitrophenyl-beta-glucoside 6-phosphate

C12H14NO11P-2 (379.0304)


   

[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(4-nitrophenoxy)oxan-2-yl]methyl phosphate

[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(4-nitrophenoxy)oxan-2-yl]methyl phosphate

C12H14NO11P-2 (379.0304)


   

(2-Chloro-5-nitrophenyl)(4-(3-chlorophenyl)piperazin-1-yl)methanone

(2-Chloro-5-nitrophenyl)(4-(3-chlorophenyl)piperazin-1-yl)methanone

C17H15Cl2N3O3 (379.049)


   

2-[[2-(4-Ethoxy-3-methoxyphenyl)-4-thiazolyl]methylthio]-5-methyl-1,3,4-thiadiazole

2-[[2-(4-Ethoxy-3-methoxyphenyl)-4-thiazolyl]methylthio]-5-methyl-1,3,4-thiadiazole

C16H17N3O2S3 (379.0483)


   

Methyl 5-chloro-4-{[3-(4-chlorophenyl)acryloyl]amino}-2-methoxybenzoate

Methyl 5-chloro-4-{[3-(4-chlorophenyl)acryloyl]amino}-2-methoxybenzoate

C18H15Cl2NO4 (379.0378)


   

N-[(4-sulfamoylanilino)-sulfanylidenemethyl]-1,3-benzodioxole-5-carboxamide

N-[(4-sulfamoylanilino)-sulfanylidenemethyl]-1,3-benzodioxole-5-carboxamide

C15H13N3O5S2 (379.0297)


   

Molybdopterin synthase intermediate

Molybdopterin synthase intermediate

C10H14N5O7PS (379.0352)


   

tetracenomycin D3(1-)

tetracenomycin D3(1-)

C20H11O8- (379.0454)


A hydroxy monocarboxylic acid anion that is the conjugate base of tetracenomycin F1, obtained by deprotonation of the carboxy group.

   

methanesulfonic acid [(2R,5R)-2-(6-amino-2-chloro-9-purinyl)-4-hydroxy-5-(hydroxymethyl)-3-oxolanyl] ester

methanesulfonic acid [(2R,5R)-2-(6-amino-2-chloro-9-purinyl)-4-hydroxy-5-(hydroxymethyl)-3-oxolanyl] ester

C11H14ClN5O6S (379.0353)


   

4-chloro-N-(3-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

4-chloro-N-(3-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

C16H14ClN3O4S (379.0394)


   

4-chloro-N-(5-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

4-chloro-N-(5-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

C16H14ClN3O4S (379.0394)


   

4-chloro-N-[(2S)-2-methyl-3-oxo-2H-indol-1-yl]-3-sulfamoylbenzamide

4-chloro-N-[(2S)-2-methyl-3-oxo-2H-indol-1-yl]-3-sulfamoylbenzamide

C16H14ClN3O4S (379.0394)


   

6-Thioguanosine monophosphate

6-Thioguanosine monophosphate

C10H14N5O7PS (379.0352)


   

5-bromo-1-[(1s)-1-(dimethylamino)-2-(methylsulfanyl)ethyl]-9h-pyrido[3,4-b]indol-6-ol

5-bromo-1-[(1s)-1-(dimethylamino)-2-(methylsulfanyl)ethyl]-9h-pyrido[3,4-b]indol-6-ol

C16H18BrN3OS (379.0354)